InFocus | 3D In Vitro News
Why to subscribe?
This news digest is for you if you are interested in the latest advancements in 3D in vitro technologies:
- organoids, spheroids, assembloids, organ-on-a-chip and microfluidic devices, as well as bioprinting and tissue engineering
- how these transform the way we further drug discovery and approach disease modelling
- how they can be used as alternatives to animal testing.
Our team strives to stay abreast of late-breaking news, emerging technologies, valuable applications and commercial successes in the field.
What will you get?
Latest and carefully selected most impactful news from trustworthy sources will be sent to you twice a month, covering the following:
- News fresh off the press
- Insights from the latest research
- Industry reports
- Our personal reading list
InFocus | 3D In Vitro News. Subscribe and read past issues below.
Subscribe to Stay Informed
Latest advancements in 3D in vitro technologies research and industry news.
* required fields
Past issues
Volume 2 | 2021
No. 2.16 | Organoids for microbiology and a way to generate a multi-layered stomach organoid
No. 2.15 | A knowledgebase for spheroids and hepatic organoids from endodermal cells
No. 2.14 | Toxicology with 3D in vitro models takes center stage
No. 2.13 | European Parliament votes on animal experiments and the rise of assembloids
No. 2.12 | Complex organoids to study SARS-CoV-2 and bladder organoids for bacterial infection
No. 2.11 | Organs-on-a-chip for pre-clinical testing and bone metastases model
No. 2.10 | The magic of microfluidics and bioprinted pancreas
No. 2.9 | Organoids that help to beat COVID and self-organizing cardioids
No. 2.8 | First-of-its-Kind 3D: Organoid Model of the Human Pancreas and Cardioids
No. 2.7 | Lung and cervical tumoroids – from the bench to the clinic
No. 2.6 | Replicating human eye in vitro and thank you for your feedback!
No. 2.5 | Host-microbiome relations with organ-on-a-chip and 3D self-organizing bone organoid
No. 2.4 | Diabetes in vitro and overcoming current limitations of organoids
No. 2.3 | Assembloids, organoid platform for ovarian cancer and 3D bioprinted hepatorganoids
No. 2.2 | A mesofluidic platform to study gut-liver-brain axis, gene therapy in retinal organoids
No. 2.1 | 2021 starts with added biological complexity of organoids and nanotoxicology
Volume 1 | 2020
No. 1.6 | Stem cells, genetic engineering, computational approaches and single-cell sequencing
No. 1.5 | 3D culture platform for β cells, long-term lung and reproducible kidney organoids
No. 1.4 | It’s time for cancer research to include human-relevant in vitro models
No. 1.3 | From lab-grown brains and lungs to leukemia-on-a-chip
No. 1.2 | Living vascularized in vitro tissue and heart-on-a-chip